Case Report
Clinical, Parasitological, and Serological Follow-Up of Dogs with Sarcoptic Mange Treated Orally with Lotilaner
Table 1
Description of the canine cohort on initial presentation.
| Dog no. | Gender | Age (years) | Weight (kg) | Body condition score [10] | DS | PS | IgG titre (%) |
| 1 | F | 3 | 49.3 | 2/9 | 257 | 8.2 | | 2 | F | 3 | 38.8 | 2/9 | 247 | 8.1 | 100 | 3 | M | 6 | 60.0 | 3/9 | 178 | 3.9 | 63.4 | 4 | F | 2 | 47.7 | 2/9 | 256 | 9.1 | 98.9 | 5 | F | 7 | 51.0 | 4/9 | 231 | 6.0 | 112 | 6 | F | 6 | 46.0 | 3/9 | 91 | 2.0 | 40.6 | 7 | F | 4 | 63.7 | 4/9 | 92 | 8.3 | 43.4 | 8 | M | 4 | 71.2 | 4/9 | 169 | 8.0 | 69.5 | 9 | F | 4 | 69.8 | 5/9 | 135 | 9.2 | 57.1 |
|
|
F: female; M: male; DS: dermatological score; PS: pruritus score.
|